| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | President and CEO | Executive Chairman
3 companies
Christoph H Westphal last filed a Form 4 in July 2021, as 10% Owner at TCRX. The filings on record cover 3 companies. From January 2015 to July 2021, the filings on record show 62 open-market purchases and 1 sale.
At the last filing, the largest reported position was 1,278,838 shares of TCRX. Net of sales, the Form 4 record there shows accumulation of 133,333 shares.
Shares as reported in the last Form 4 for each company; the most recent is from July 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 5,900 | $12.25 | $72,276.00 | +0.2% | |
| Jun 6, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 6,000 | $12.56 | $75,360.00 | +0.2% | |
| Jun 2, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 10,000 | $12.99 | $129,900.00 | +0.3% | |
| May 31, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 22,300 | $12.68 | $282,664.00 | +0.7% | |
| May 26, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 28,600 | $12.84 | $367,214.00 | +0.9% | |
| May 24, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 30,334 | $12.42 | $376,635.27 | +1.0% | |
| May 20, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 7,914 | $11.06 | $87,494.00 | +0.3% | |
| May 18, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 33,400 | $11.10 | $370,708.00 | +1.1% | |
| May 16, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 15,469 | $10.25 | $158,624.21 | +0.5% | |
| May 12, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 30,217 | $10.12 | $305,863.78 | +1.0% |